Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Bookmark and Share
Published: 5 Jun 2016
Views: 2028
Prof James Perry - University of Toronto, Toronto, Canada

Prof Perry presents at ASCO 2016, a Canadian-led randomised phase III trial found that adding temozolomide chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide, significantly improved survival of elderly patients with glioblastoma, reducing the risk of death by 33%.

Read the news story or watch the video interview for more.